A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants

NCT07554365 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AirNexis Therapeutics, Inc.